DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Aldara (Imiquimod) - Current Clinical Trials

 
 



Aldara Related Clinical Trials

A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy [Completed]

Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma [Recruiting]

Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy [Recruiting]

Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses [Recruiting]

Study Comparing Imiquimod Cream, 3.75% to Zyclara� (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis [Recruiting]

Aldara for the Treatment of Extensive Alopecia Areata [Completed]

Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands [Completed]

The Effects of Aldara as an Adjunct to Laser Treatment [Recruiting]

Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer [Recruiting]

Treatment Study for Actinic Cheilitis Comparing Imiquimod 5% and Photodynamic Therapy [Recruiting]

Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients [Recruiting]

Topical Imiquimod for Bowen's Disease of the Head and Neck [Enrolling by invitation]

Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks [Enrolling by invitation]

Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna [Recruiting]

ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-Trial [Recruiting]

Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod [Recruiting]

Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma [Recruiting]

Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream [Completed]

Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial Neoplasia [Not yet recruiting]

Effect of Topical Imiquimod on Lentigo Maligna [Recruiting]

Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases [Recruiting]

Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2) [Recruiting]

Immunevasion of Human Papillomavirus (HPV) in Vulvar Intraepithelial Neoplasia 2/3 and Anogenital Warts and Efficiency and Mechanisms of Imiquimod Treatment [Recruiting]

Study of Immune Responses to Influenza Vaccination With or Without Imiquimod Application in Untreated CLL Patients [Recruiting]

Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1 [Recruiting]

Imiquimod 5% Cream in Plaque-Type Morphea: A Pilot, Prospective Open-Label Study [Withdrawn]

Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal [Recruiting]

Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5% [Completed]

A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients [Completed]

Evaluation of Two Different Non-Invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions [Active, not recruiting]

Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma [Recruiting]

Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face [Recruiting]

Treatment of Primary Basal Cell Carcinomas of the Skin With Combination of Topical Imiquimod and Cryosurgery [Recruiting]

Comparison of Five Treatments in Patients With Plantar Warts [Recruiting]

Safety and Efficacy Study to Evaluate Imiquimod 5% Cream Applied 3x Per Week for 8 or 12 Weeks in Low Risk Nodular Basal Cell Carcinoma [Completed]

Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia [Recruiting]

Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses [Completed]

A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma [Completed]

Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis [Completed]

Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer [Active, not recruiting]

Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses [Recruiting]

Study to Evaluate the Effects of Imiquimod and Tumor Lysate Vaccine Immunotherapy in Adults With High Risk or Recurrent/Post-Chemotherapy WHO Grade II Gliomas [Recruiting]

Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis [Completed]

Anal Dysplasia Study of Men Who Have Sex With Men Living With HIV [Not yet recruiting]

Aldara for the Treatment of Large and/or Multiple sBCC [Active, not recruiting]

Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs) [Active, not recruiting]

Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs) [Active, not recruiting]

Toll-like Receptor (TLR) 7 Agonist and Radiotherapy for Breast Cancer With Skin Metastases [Recruiting]

Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC) [Recruiting]

Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses [Completed]

Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva [Recruiting]

A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base [Not yet recruiting]

Open-Label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream [Active, not recruiting]

Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma [Recruiting]

Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage [Completed]

Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer [Active, not recruiting]

NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting) [Completed]

Imiquimod in Children With Plaque Morphea [Recruiting]

Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia [Active, not recruiting]

Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts [Recruiting]

Peptide Vaccination Associated With Tumoral Immunomodulation in Patients With Advanced Metastatic Melanoma [Recruiting]

Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts [Recruiting]

Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts [Recruiting]

Long-Term Effects of Imiquimod and Diclofenac in Actinic Keratoses [Recruiting]

A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence [Completed]

Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma [Active, not recruiting]

Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin [Recruiting]

Vaccine Therapy With or Without Montanide ISA-51 and/or Imiquimod in Treating Patients With Melanoma That Has Been Removed By Surgery [Recruiting]

1-Year Follow up to the 1473-IMIQ Study [Completed]

Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis [Recruiting]

Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses [Recruiting]

Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients [Recruiting]

Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Recovering From Lymphopenia Caused by Temozolomide

Daclizumab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia [Recruiting]

Pilot Study of Oral 852A for Elimination of High-Grade Dysplasia in Barrett's Esophagus [Recruiting]

A Vaccine Study for High Risk Cancers [Recruiting]

The Impact of Total Body Skin Examination on Skin Cancer Detection [Recruiting]

Dendritic Cells in Lung Cancer [Recruiting]

A Study to Follow up Recurrence Rates of Actinic Keratoses One Year After Completion of Study 1487-IMIQ [Completed]

Follow-up Study to Evaluate Sustained Clearance Rates of Actinic Keratoses up to One Year [Active, not recruiting]

Prospective Randomized Trial: Curettage Versus Excision in Nodular and Superficial Basal Cell Carcinomas [Recruiting]

Viral Load Determination and Biomarkers of High Risk Human Papillomavirus (HPV) - Types in HIV-Positive Men [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014